日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Redox-Responsive Selenium-Containing Nanomedicine Enables Dual Antioxidant System Inhibition to Overcome Platinum Resistance and Enhance Immunotherapy in Bladder Cancer

一种氧化还原响应型含硒纳米药物可通过双重抗氧化系统抑制克服铂类耐药性并增强膀胱癌的免疫疗法

Gao, Yunhao; Yang, Feiya; Yin, Lu; Wang, Wenkuan; Wang, Kai; Zhang, Hanchen; Zhang, Zhen; Chen, Dong; Pan, Kehao; Liu, Wen; Jia, Bin; Xu, Chun; Cao, Zheng; Chen, Aolong; Pei, Delong; Xiao, Haihua; Shao, Zhiqiang; Xing, Nianzeng

Pre-diagnostic plasma proteomics profile uncovers new biomarkers and mechanistic insights for incident kidney cancer

诊断前血浆蛋白质组学分析揭示了肾癌发病的新生物标志物和机制见解

Liu, Wen; Chen, Wei; Dong, Dahai; Zhang, Guiming; Xing, Nianzeng

Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01

Saruparib联合雄激素受体通路抑制剂治疗转移性激素敏感性前列腺癌:EvoPAR-Prostate01

Azad, Arun A; Agarwal, Neeraj; Armstrong, Andrew J; Hellmis, Eva; Sugimoto, Mikio; Ürün, Yüksel; Xing, Nianzeng; Aregay, Mehreteab; Lima, Julianne; Meulendijks, Didier; Chi, Kim N

Clinical Characteristics and Management of Two Cases of Complete Androgen Insensitivity Syndrome With Germ Cell Tumors

两例伴有生殖细胞肿瘤的完全性雄激素不敏感综合征的临床特征及治疗

Wang, Fangming; Wang, Dong; Li, Jianxing; Xing, Nianzeng

Clinical value of [(18)F]AlF-Thretide PET/CT and early-time-point PET acquisition in the detection and staging of prostate cancer

[(18)F]AlF-Thretide PET/CT 和早期 PET 采集在检测和分期前列腺癌中的临床价值

Cheng, Xin; Hou, Guozhu; Wang, Mingshuai; Zheng, Shan; Yao, Wei; Wang, Xuejuan; Zheng, Rong; Xing, Nianzeng; Zhang, Jingjing

High-resolution transcriptome atlas of bladder cancer highlights the functional myeloid subsets in modulating immune microenvironment

膀胱癌高分辨率转录组图谱突显了髓系细胞亚群在调节免疫微环境中的功能作用

Liu, Jiachen; Shi, Zhen; Li, Yajian; Ma, Jie; Yao, Jiaying; Yuan, Zan; Wang, Yuanhao; Yang, Chunyuan; Li, Xiao; Xing, Nianzeng; Zhu, Yunping; Zhang, Jianhong; Wu, Li

Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET-Targeted Prostate Biopsy for Prostate Cancer Diagnosis

经直肠超声引导前列腺活检联合或不联合PSMA-PET靶向前列腺活检在前列腺癌诊断中的应用

Jiao, Jianhua; Ma, Shuaijun; Wu, Peng; Song, Xiyu; Cui, Hongyong; Zhang, Jingliang; Shang, Lei; Zhang, Wuhe; Sun, Yi; Gao, Jixue; Zhao, Weihong; Zheng, Wei; Jing, Yuming; Yang, Xiaojian; Zhang, Jing; Wang, Wenwen; Zhang, Qiang; Xing, Nianzeng; Wen, Weihong; Shi, Yongquan; Kang, Fei; Qin, Weijun

Preliminary clinical practice of radical prostatectomy without preoperative biopsy

不经术前活检行根治性前列腺切除术的初步临床实践

Liu, Ranlu; Yin, Lu; Ma, Shenfei; Yang, Feiya; Lian, Zhenpeng; Wang, Mingshuai; Lei, Ye; Dong, Xiying; Liu, Chen; Chen, Dong; Han, Sujun; Xu, Yong; Xing, Nianzeng

Combined treatment with anti-PSMA antibody and human peripheral blood-derived NK cells for castration-resistant prostate cancer.

采用抗PSMA抗体和人外周血来源的NK细胞联合治疗去势抵抗性前列腺癌

Wang Fangming, Xing Nianzeng, Li Jianxing

A multifunctional T-cell engager containing CD80 enhances prostate cancer treatment.

含有 CD80 的多功能 T 细胞衔接器可增强前列腺癌的治疗效果

Nie Disen, Jiang Yao, Li Hui, Zhang Keying, Li Zhengxuan, Lu Tong, Li Yu, Han Donghui, Shi Changhong, Xing Nianzeng, Yang Fa, Wen Weihong, Qin Weijun